Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies. | Cell Mol Life Sci | 2023 | 37632572 | PubTator, text mining | PubMed |
| The Potential Usefulness of the Expanded Carrier Screening to Identify Hereditary Genetic Diseases: A Case Report from Real-World Data. | Genes (Basel) | 2023 | 37628702 | PubTator, text mining | PubMed |
| A Role for Genetic Modifiers in Tubulointerstitial Kidney Diseases. | Genes (Basel) | 2023 | 37628633 | PubTator, text mining | PubMed |
| Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome. | BMC Med Genomics | 2023 | 37596645 | PubTator, text mining | PubMed |
| Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys. | Front Pharmacol | 2023 | 37587982 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
| Reproductive Carrier Screening Results With Maternal Health Implications During Pregnancy. | Obstet Gynecol | 2023 | 37562044 | PubTator, text mining | PubMed |
| Alport Syndrome and Oral Mucous Membrane Pemphigoid: An Interesting Case. | Cureus | 2023 | 37551211 | PubTator, text mining | PubMed |
| SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling. | Front Immunol | 2023 | 37545510 | PubTator, text mining | PubMed |
| [COL4A5 genotypes and clinical characteristics of children with Alport syndrome]. | Zhongguo Dang Dai Er Ke Za Zhi | 2023 | 37529956 | PubTator, text mining | PubMed |
| Case report: A case report of Alport syndrome caused by a novel mutation of COL4A5. | Front Genet | 2023 | 37529776 | PubTator, text mining | PubMed |
Predictability of Nailfold Capillaroscopic Score in Diagnosing Retinopathy in Patients with Type 2 Diabetes Mellitus and its Utility as a Non-Invasive Tool for Differentiating from those Not Having Retinopathy: A Pilot Observational Cross-Sectional Analytical Study. | Indian J Dermatol | 2023 | 37529446 | PubTator, text mining | PubMed |
| At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children. | JAMA Netw Open | 2023 | 37523181 | PubTator, text mining | PubMed |
| Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models. | Biomedicines | 2023 | 37509442 | PubTator, text mining | PubMed |
| Research progress on endoplasmic reticulum homeostasis in kidney diseases. | Cell Death Dis | 2023 | 37500613 | PubTator, text mining | PubMed |
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel. | Biomark Res | 2023 | 37491309 | PubTator, text mining | PubMed |
| A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape. | Front Oncol | 2023 | 37476379 | PubTator, text mining | PubMed |
| Clinical utility of genetic testing in Indian children with kidney diseases. | BMC Nephrol | 2023 | 37464296 | PubTator, text mining | PubMed |
| Contemporary Monoclonal Antibody Utilization in Glomerular Diseases. | Mayo Clin Proc Innov Qual Outcomes | 2023 | 37448529 | PubTator, text mining | PubMed |
| Albuminuria-Related Genetic Biomarkers: Replication and Predictive Evaluation in Individuals with and without Diabetes from the UK Biobank. | Int J Mol Sci | 2023 | 37446387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=15